(Press-News.org) Richmond, Va. (November 13, 2012) – In laboratory experiments, scientists have eliminated metastasis, the spread of cancer from the original tumor to other parts of the body, in melanoma by inhibiting a protein known as melanoma differentiation associated gene-9 (mda-9)/syntenin. More than 1 million cases of skin cancer are diagnosed each year in the U.S., and melanoma is the deadliest form. With further research, the approach used by the scientists could lead to targeted therapies that stop metastasis in melanoma and potentially a broad range of additional cancers.
The study published online in the journal Cancer Research was led by Paul B. Fisher, M.Ph., Ph.D., Thelma Newmeyer Corman Endowed Chair in Cancer Research and program co-leader of Cancer Molecular Genetics at Virginia Commonwealth University Massey Cancer Center, chairman of VCU's Department of Human and Molecular Genetics and director of the VCU Institute of Molecular Medicine. Fisher and his colleagues found that Raf kinase inhibitor protein (RKIP) interacted with and suppressed mda-9/syntenin. Mda-9/syntenin was originally cloned in Fisher's laboratory, and was shown in previous studies to interact with another protein, c-Src, to start a series of chemical reactions that lead to increased metastasis.
"Prior research suggests that RKIP plays a seminal role in inhibiting cancer metastasis, but, until now, the mechanisms underlying this activity were not clear," says Fisher. "In addition to providing a new target for future therapies, there is potential for using these two genes as biomarkers for monitoring melanoma development and progression."
Through their experiments, the scientists discovered that RKIP physically binds with mda-9/syntenin, and this physical interaction inhibits mda-9/syntenin expression. This finding opens the possibility of developing small molecules that mimic RKIP to be used as drugs to treat metastasis in melanoma and other cancers.
Additionally, the team found that levels of mda-9/syntenin were higher than levels of RKIP in malignant and metastatic melanoma cells while levels of RKIP were higher than levels of mda-9/syntenin in healthy melanocytes, which are the cells that produce pigment in the skin, eyes and hair. The inverse relationship between the two proteins suggests that changes in their levels of expression could be used as a diagnostic tool, enabling clinicians to track the development of the disease or gauge a patient's response to treatments.
"Our findings represent a major breakthrough in understanding the genetic mechanisms that lead to metastasis in melanoma. Prior studies have shown that levels of mda-9/syntenin are elevated in a majority of cancers, including melanoma, suggesting that our findings could be applicable for a wide range of diseases," says Fisher.
Now that the researchers have demonstrated the ability of RKIP to inhibit mda-9/syntenin-mediated metastasis, they are focusing their attention on developing small molecules imitating RKIP that could be used as new treatments for melanoma.
INFORMATION:
Fisher collaborated on this study with Devanand Sarkar, M.B.B.S., Ph.D., Harrison Scholar at VCU Massey Cancer Center, Blick Scholar and assistant professor in the Department of Human and Molecular Genetics at VCU School of Medicine and member of the VCU Institute of Molecular Medicine; Swadesh K. Das, Ph.D., instructor in the Department of Human and Molecular Genetics at VCU School of Medicine and VCU Institute of Molecular Medicine; Sujit K. Bhutia, Ph.D., Upneet K. Sokhi, Ph.D. graduate student, Belal Azab, Ph.D., and Zhao-zhong Su, Ph.D., all from the Department of Human and Molecular Genetics at VCU School of Medicine; Talha Anwar, Ph.D., Erika L. Moen, Ph.D., and Devasis Chatterjee, Ph.D., all from the Department of Medicine at Rhode Island Hospital; and Maurizio Pellecchia, Ph.D., from the Sanford-Burnham Medical Research Institute in La Jolla, CA.
Funding for this study was supported in part by National Institutes of Health grants 1R01 CA097318, P01 CA104177 and P20 RR17695; the National Foundation for Cancer Research; the Goldhirsh Foundation for Brain Tumor Research; the Dana Foundation; the American Cancer Society; and the Samuel Waxman Cancer Research Foundation.
The full manuscript of this study is available online at: http://cancerres.aacrjournals.org/content/early/2012/10/11/0008-5472.CAN-12-0402.abstract?sid=6fae281f-1cec-4331-b5bd-6019f04ac54b
News directors: Broadcast access to VCU Massey Cancer Center experts is available through VideoLink ReadyCam. ReadyCam transmits video and audio via fiber optics through a system that is routed to your newsroom. To schedule a live or taped interview, contact John Wallace, (804) 628-1550.
About VCU Massey Cancer Center
VCU Massey Cancer Center is one of only 67 National Cancer Institute-designated institutions in the country that leads and shapes America's cancer research efforts. Working with all kinds of cancers, the Center conducts basic, translational and clinical cancer research, provides state-of-the-art treatments and clinical trials, and promotes cancer prevention and education. Since 1974, Massey has served as an internationally recognized center of excellence. It has one of the largest offerings of clinical trials in Virginia and serves patients in Richmond and in four satellite locations. Its 1,000 researchers, clinicians and staff members are dedicated to improving the quality of human life by developing and delivering effective means to prevent, control and ultimately to cure cancer. Visit Massey online at www.massey.vcu.edu or call 877-4-MASSEY for more information.
About VCU and the VCU Medical Center
Virginia Commonwealth University is a major, urban public research university with national and international rankings in sponsored research. Located in downtown Richmond, VCU enrolls more than 31,000 students in 222 degree and certificate programs in the arts, sciences and humanities. Sixty-six of the programs are unique in Virginia, many of them crossing the disciplines of VCU's 13 schools and one college. MCV Hospitals and the health sciences schools of Virginia Commonwealth University compose the VCU Medical Center, one of the nation's leading academic medical centers. For more, see www.vcu.edu.
END
VIDEO:
On Nov. 13, 2012, a narrow corridor in the southern hemisphere experienced a total solar eclipse. The corridor lay mostly over the ocean but also cut across the northern tip...
Click here for more information.
On Nov. 13, 2012, a narrow corridor in the southern hemisphere experienced a total solar eclipse. The corridor lay mostly over the ocean but also cut across the northern tip of Australia where both professional and amateur astronomers gathered to watch.
During ...
The twenty-fifth tropical depression of the western North Pacific Ocean season formed today and is already affecting southern Vietnam. NASA's Aqua satellite passed over Tropical Depression 25W and captured a visible image of the storm that showed its northern quadrant raining over the country.
When NASA's Aqua satellite passed over newborn Tropical Depression 25W (TD25W) on Nov. 14 at 0638 UTC (1:38 a.m. EDT), the Moderate Resolution Imaging Spectroradiometer (MODIS) instrument captured a visible image of the storm. At the time of the image, the strongest thunderstorms ...
Sometimes simplicity is best. Two Northwestern University researchers have discovered a remarkably easy way to make nanofluidic devices: using paper and scissors. And they can cut a device into any shape and size they want, adding to the method's versatility.
Nanofluidic devices are attractive because their thin channels can transport ions -- and with them a higher than normal electric current -- making the devices promising for use in batteries and new systems for water purification, harvesting energy and DNA sorting.
The "paper-and-scissors" method one day could ...
An international research team including scientists from the University of Toronto's Faculty of Medicine has discovered a link between a mutation in an immune system gene and Alzheimer's disease.
Using data from 25,000 people, researchers from the Faculty of Medicine and University College London's Institute of Neurology discovered that a rare genetic mutation in the TREM2 gene — which helps trigger immune system responses — is also associated with increased risk of Alzheimer's. The discovery supports an emerging theory about the role of the immune system in the disease. ...
Noting that active-duty servicewomen have higher rates of unintended pregnancy than the general population and lower reported contraception use, one researcher at Women & Infants Hospital is suggesting the answer might be a review of the health care offered to females in the military and veterans.
Vinita Goyal, MD, MPH, published the study "Unintended pregnancy and contraception among active-duty servicewomen and veterans" in a recent issue of the American Journal of Obstetrics & Gynecology. As part of her research, conducted in cooperation with the Veteran's Administration ...
Georgia Tech, along with partner research organizations on the Keeneland Project, including the University of Tennessee-Knoxville, the National Institute for Computational Sciences and Oak Ridge National Laboratory, announced today that the project has completed installation and acceptance of the Keeneland Full Scale System (KFS). This supercomputing system, which is available to the National Science Foundation (NSF) scientific community, is designed to meet the compute-intensive needs of a wide range of applications through the use of NVIDIA GPU technology. In achieving ...
Not only is Oak Ridge National Laboratory's Titan the world's most powerful supercomputer, it is also one of the most energy-efficient.
Titan came in at number three on the Green500 list. Organized by Virginia Tech's Wu-chun Feng and Kirk Cameron, the list takes the world's 500 most powerful supercomputers—as ranked by the Top500 list—and reorders them according to how many calculations they can get per watt of electricity.
The Green500 list was announced Wednesday during the SC12 supercomputing conference in Salt Lake City.
Titan's position reflects a significant ...
Compared to the nation, a higher proportion of children in California are uninsured, one in every 10 children or more than 1.1 million in 2011. More of California's children have public health insurance and fewer through their parents' employer. And, over the past three years, a decade of advances in California children's public insurance enrollment has stalled, as coverage in Healthy Families (California's children's health insurance program) declined as a result of reductions in state government funding.
These are just a few of the findings in a new report from the ...
GAINESVILLE, Fla. --- The great white shark is one of the largest living predatory animals and a magnet for media sensationalism, yet its evolutionary history is as misunderstood as its role as a menace.
Originally classified as a direct relative of megatooth sharks, the white shark's evolutionary history has been debated by paleontologists for the last 150 years. In a study appearing in print and online today in the journal Palaeontology, University of Florida researchers name and describe an ancient intermediate form of the white shark, Carcharodon hubbelli, which shows ...
RIVERSIDE, Calif. — The human nose has millions of olfactory neurons grouped into hundreds of different neuron types. Each of these neuron types expresses only one odorant receptor, and all neurons expressing the same odorant receptor plug into one region in the brain, an organization that allows for specific odors to be sensed.
For example, when you smell a rose, only those neurons that express a specific odor receptor that detects a chemical the rose emits get activated, which in turn activates a specific region in the brain. Rotten eggs on the other hand, activate ...
